- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Panitumumab – July 2014
PANITUMUMAB, injection, 100 mg/5 mL and 400 mg/20 mL, Vectibix®, Amgen Australia Pty Ltd.
Last updated
8 November 2023